-
Electronic (PDF)
-
Site License
-
Enterprisewide
HeartWare Limited Product Pipeline Analysis
Global Markets Direct, January 2009, Pages: 23
HeartWare Limited Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.
1 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Company Snapshot 6
2.1 Key Information 6
2.2 Company Overview 6
3 HeartWare Limited Pipeline Products 7
3.1 HeartWare Limited Product Pipeline Analysis 7
3.1.1 HeartWare Limited Pipeline Products By Equipment Type 7
3.1.2 HeartWare Limited Pipeline Products By Development Stage 8
3.1.3 HeartWare Limited Pipeline Products By Therapy Area 8
3.1.4 HeartWare Limited Pipeline Products By Clinical Trials 9
3.1.5 HeartWare Limited Pipeline Products By News Summary 9
3.2 HVAD System 10
3.2.1 Product Status 10
3.2.2 Product Description 10
3.2.3 Product Milestone 11
3.2.4 HVAD SystemClinical Trials 1 11
3.2.5 HVAD SystemClinical Trials 2 12
3.2.6 Product Patent Details 12
3.3 MVAD System 13
3.3.1 Product Status 13
3.3.2 Product Description 13
3.3.3 Product Patent Details 13
3.4 HeartWare IV-VAD 14
3.4.1 Product Status 14
3.4.2 Product Description 14
3.4.3 Product Patent Details 15
3.5 PedVAD 15
3.5.1 Product Status 15
3.5.2 Product Description 16
3.6 TETS Technology 16
3.6.1 Product Status 16
3.6.2 Product Description 16
4 Recent Developments 17
4.1 Product News 17
4.1.1 May 05, 2008: HeartWare Receives Conditional Approval Of IDE 17
4.1.2 Jul 13, 2007: Heartware Announces Clinical Trial Update 17
4.1.3 Mar 09, 2007: Heartware Ltd To Launch HVAD Heart Device In Europe 18
4.1.4 May 22, 2006: HeartWare Receives Regulatory Approval For HVAD Implants In United Kingdom 18
4.2 Product Approvals 18
4.2.1 May 05, 2008: HeartWare Receives Conditional Approval Of IDE 18
4.2.2 May 22, 2006: HeartWare Receives Regulatory Approval For HVAD Implants In United Kingdom 19
4.3 Clinical Trials 20
4.3.1 Jul 13, 2007: Heartware Announces Clinical Trial Update 20
5 Appendix 21
5.1 Methodology 21
5.1.1 Coverage 21
5.1.2 Secondary Research 22
5.1.3 Primary Research 22
5.1.4 Expert Panel Validation 23
5.2 Contact Us 23
5.3 About us23
5.4 Disclaimer 23
Executive Summary
1.2 List of Figures
Figure 1: HeartWare Limited Pipeline Products By Development Stage 8
Figure 2: HeartWare Limited Pipeline Products By News Summary 9
Figure 3: Global Markets Direct Methodology 21
The following companies are the major competitors of HeartWare Limited:
Thoratec Corporation
Ventracor Limited
ABIOMED, Inc.
Jarvik Heart, Inc.
SynCardia Systems, Inc.
World Heart Corporation
Berlin Heart GmbH
MicroMed Cardiovascular, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
